GENAFEN

This brand name is authorized in Nigeria.

Active ingredients

The drug GENAFEN contains one active pharmaceutical ingredient (API):

1	Ibuprofen UNII WK2XYI10QM - IBUPROFEN
	Ibuprofen is a propionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation.
	Read more about Ibuprofen

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-1511	Suspension	GENAFEN ORAL SUSPENSION SUSP 100 mcg/5 mL 1X100ML	GENAFEN ORAL SUSPENSION IBUPROFEN BP 100MG/5ML IBUPROFEN BP 100MG/5ML EXCIPIENT Q.S A4-1511 Drugs Imported Products 1X100ML Over The Counter (OTC) 14/06/2022 GENEITH PHARMACEUTICALS LIMITED, ADEWALE CRESCENT, OFF EWENLA STREET, OSHODI ISOLO LAGOS 8122912281 ngouzoamaka@yahoo.com STALLION LABORATORIES PVT.LTD, C1B, 305, 2 & 3 GIDC, KERALA ( BAVIA) DIST. AHMEDABAD ( GUJARAT )INDIA., India	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AE01	Ibuprofen	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives
Discover more medicines within M01AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-1511